Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias.

Saved in:
Bibliographic Details
Title: Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias.
Authors: Punatar S; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Kumbhalwar K; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India., Kalantri SA; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Gokarn A; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Nayak L; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Chichra A; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Mirgh S; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Jindal N; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Mathew L; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India., Kannan S; Department of Biostatistics/Paymaster Shodhika/Advanced Centre For Treatment Research & Education in Canter, Tata Memorial Centre, Navi Mumbai, India., Khattry N; HSCT unit, Department of Medical Oncology/Advanced Centre For Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India.
Source: Blood cell therapy [Blood Cell Ther] 2025 May 25; Vol. 8 (2), pp. 210-216. Date of Electronic Publication: 2025 May 25 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Asia-Pacific Blood and Marrow Transplantation Country of Publication: Japan NLM ID: 9918333884906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2432-7026 (Electronic) Linking ISSN: 24327026 NLM ISO Abbreviation: Blood Cell Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first